Speeding up sepsis diagnostics with phenotypic AST for better patient care

Dr. Ágnes Pál-Sonnevend highlights the critical role of time in sepsis diagnostics.

The impact of faster phenotypic testing on
patient outcomes

While advancements like mass spectrometry have improved bacterial identification, rapid antimicrobial susceptibility reporting remains a challenge, particularly in hospitals facing high rates of antimicrobial resistance. Faster phenotypic testing could significantly enhance patient treatment, ensuring clinicians have timely data to combat multi drug-resistant infections.

Addressing logistical barriers and improving microbiology service efficiency will not only advance patient care but also elevate the role of microbiologists within the medical field.

This video was filmed at ESCMID Global 2025 in Vienna, Austria.